FindMyKOL
Clinical trialNCT00164762CompletedObservational

Nevirapine Resistance Study: Nevirapine Resistance Among HIV-Infected Mothers

NCT00164762 is an observational study sponsored by Centers for Disease Control and Prevention. As of 21 Nov 2026, it is completed. It studies HIV Infections. The registry lists an enrollment of 126 participants at 1 site in 1 country. The registry lists a start date of 30 Jun 2005. One of its registered investigators has a FindMyKOL profile.

View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT00164762
FieldValue
Registry IDNCT00164762
StatusCompleted
Study typeObservational study
Lead sponsorCenters for Disease Control and Prevention
Enrollment126
Registered sites1
Countries1
ConditionsHIV Infections
Start30 Jun 2005
Study completion30 Nov 2006
Last update posted1 Oct 2007

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine whether the addition of zidovudine (ZDV) and lamivudine (3TC) at the onset of labor and for up to seven days postpartum to single-dose nevirapine (NVP) is associated with a lower prevalence of NVP-resistant HIV compared to single-dose NVP without ZDV+3TC.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Malawi1 site
  • Area 25 Health Center

    Lilongwe

Sites by country

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT00164762

Each answer restates registry values shown on this page.

What is NCT00164762?

NCT00164762 is an observational study sponsored by Centers for Disease Control and Prevention. It studies HIV Infections.

Who leads NCT00164762?

The registry names Charles Van der Horst, MD (principal investigator, University of North Carolina, Chapel Hill), Denise J Jamieson, MD, MPH (principal investigator, Centers for Disease Control and Prevention), Peter Kazembe, MB ChB (principal investigator, Kamuzu Central Hospital) and 1 more official as overall officials.

Where does NCT00164762 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: Malawi.

When did NCT00164762 end?

The registry lists a study completion date of 30 Nov 2006. The sponsor last updated the record on 1 Oct 2007.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.